Global Stroke Management Market Report 2024: Growth Rate, Major Segments And Regions

Ischemic stroke market research report: by diagnosis (CT, MRI, carotid ultrasound, cerebral angiography), drug class (tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive), surgery, end user – Global forecast till 2023Market Scenario:Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain.

The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.

According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually.

As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.Avail a Free Sample Insights @ https://www.marketresearchfuture.com/sample_request/5423 The global market for ischemic stroke is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023.Some of key the players in the Americas ischemic stroke market are Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.),  Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.),  Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.),  GE Healthcare (U.S.),  Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and othersSegmentation:The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users.On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others.On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and othersOn the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomyOn the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.Browse Complete Premium Research Report@ https://www.marketresearchfuture.com/reports/ischemic-stroke-market-5423 Intended Audience:Ischemic Stroke Drug SuppliersIschemic Stroke Drug ManufacturersResearch and Development (R) CompaniesMedical Research LaboratoriesAcademic Medical Institutes and UniversitiesAbout Market Research Future:At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:Market Research Future +1 646 845 9312Email: [email protected]

Global Stroke Disorder & Treatment market Information,by types (ischemic stroke, hemorrhagic strokes) by medicine (an-ticoagulants, anti-hypertensive) by treatment (tissue plasminogen activator (TPA), endovascular procedures)- Forecast to 2027Market ScenarioThe global stroke disorder and treatment market is presumed to demonstrate a healthy CAGR during the forecast period (2016-2022) owing to the rising high blood pressure patients, asserts Market Research Future (MRFR).

Stroke is referred to as the condition which occurs when clot is formed in the artery and oxygen supply is cut off.

Brain cells thus get deprived of oxygen and start to die.

Stroke is considered as one of the leading causes of death across the world with higher prevalence in the geriatric population.Drivers and Constraints Impacting the MarketWith increasing consumption of alcohol and diabetic patients, the global stroke disorder and treatment market is likely to flourish.

Also, the increasing prevalence of cardiovascular diseases is highly influencing the market across the globe.

Ischemic stroke generally occurs due to an obstruction within a blood vessel which supplies blood to the brain.By mode of medicine, the global stroke disorder and treatment market has been segmented into anticoagulants/antiplatelet, anti-hypertensive.By mode of treatment, the global stroke disorder and treatment market has been segmented into tissue plasminogen activator (TPA), carotid endarterectomy, surgical treatment, endovascular procedures, and others.

1 Nov 2018 – This report focuses on top manufacturers in Global Market.The Global Mobile Stroke Unit Market is expected to display higher growth rate over the next seven years.

The mobile stroke unit market is subject to witness a substantial growth due to the growing geriatric population, growing prevalence of stroke conditions, rising occurrence of chronic diseases, surge in healthcare costs, and recent technological advancements in the healthcare sector.

However, absence of expertise and increase in number of reimbursement issues are restraining the market growth, in the recent years.

Yet, technological advancements such as the development of big multi-service mobile stroke unit (MSTU) are expected to fuel the growth of mobile stroke unit market in the upcoming years.